Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Charmacy Pharmaceutical Co., Ltd. Share Issue/Capital Change 2015

Dec 1, 2015

50500_rns_2015-12-01_572fa920-d636-4e81-8738-5691a5d7e9bd.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份,請使用本表格

如 閣下欲以本身名義登記將獲發行的香港發售股份,請使用本表格
Staple your
payment
here
請將股款
緊釘在此
This Application Form uses the same terms as defined in the prospectus of Chuangmei Pharmaceutical Co., Ltd. (the
Company”) dated 2 December 2015 (the “Prospectus”).本申請表格使用創美藥業股份有限公司(「本公司」)於2015
年12月2日刊發的招股說明書(「
招股說明書*」)所界定的詞語。
Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong
Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in
the United States without registration or an exemption from registration under the U.S. Securities Act.本申請表格及招股
說明書概不構成在香港以外司法權區要約出售或游說要約購買香港發售股份。若無根據美國證券法登記或豁免登
記,香港發售股份不得在美國提呈發售或出售。

This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of that jurisdiction. 任何根據當地法例不得發送、派發或複製本申請表格及招股說明書的司法權區內概不得發送或派 發或複製(不論方式,亦不論全部或部分)本申請表格及招股說明書。 Copies of the Prospectus, all related Application Forms and the other documents specified in the “Documents Delivered to the Registrar of Companies and Available for Inspection” section in Appendix VIII to the Prospectus, have been registered by the Registrar of Companies in Hong Kong. Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “ Hong Kong Stock Exchange ”), Hong Kong Securities Clearing Company Limited (“ HKSCC ”), the Securities and Futures Commission of Hong Kong (the “ SFC ”) and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents. 招股說明書、所有相關申請表格及招股說明書附錄八「送呈公司註 冊處處長及備查文件」一節所述其他文件已送呈香港公司註冊處處長登記。香港交易及結算所有限公司、香港聯 合交易所有限公司(「 香港聯交所 」)、香港中央結算有限公司(「 香港結算 」)、香港證券及期貨事務監察委員會(「 證 監會 」)及香港公司註冊處處長對此等文件的內容概不負責。 CHUANGMEI PHARMACEUTICAL CO., LTD.[*] 創美藥業股份有限公司 (a joint stock limited liability company established in the People’s Republic of China) (於中華人民共和國註冊成立的股份有限公司) Stock code : 2289 股份代號 : 2289 Maximum Offer Price : HK$8.60 per Hong Kong Offer Share, plus brokerage fee of 1.0%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) 最高發售價 : 每股香港發售股份8.60港元,另加1.0%經紀佣 金、0.0027%證監會交易徵費及0.005%聯交所 交易費(須於申請時以港元繳足,多繳款項將予 退還) You should read this Application Form in conjunction with the Prospectus, which contains further information on 一 , 一 。 the application procedures. 招股說明書尚有關於申請程序的進 步資料 本申請表格應與招股說明書 併閱讀 Application Form 申請表格 To: Chuangmei Pharmaceutical Co., Ltd. 致:* 創美藥業股份有限公司 Sole Global Coordinator 獨家全球協調人 The Hong Kong Underwriters 香港包銷商

  • Applicants’ declaration

I/We agree to the terms and conditions and application procedures in this Application Form and the Prospectus. Please refer to the “Effect of completing and submitting this Application Form” section of this Application Form.

Warning: Only one application may be made for the benefit of any person. Please refer to the last four bullet points of “Effect of completing and submitting this Application Form” section.

申請人聲明 本人╱吾等同意本申請表格及招股說明書的條款及條 件以及申請程序。見本申請表格「填寫及遞交本申請 表格的效用」一節。

一 警告:任何人士只限作出 次為其利益而進行的認購 。 一 申請 請參閱「填寫及遞交本申請表格的效用」 節最 後四點。

  • For identification purpose only

  • 僅供識別

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份,請使用本表格

Signed by (all) applicant(s) (all joint applicants must sign): 由(所有)申請人簽署(所有聯名申請人必須簽署):

For Broker use 此欄供經紀填寫 Lodged by 遞交申請的經紀 Broker No. 經紀號碼 Broker’s Chop 經紀印章

Date: 日期: / / D 日 M 月 Y 年

Number of Hong Kong Offer Shares applied for (not more than 1,400,000 H shares) 申請香港發售股份數目(不超過1,400,000股H股)

Total amount 總額

Cheque/banker’s cashier order number 支票╱銀行本票號碼

Name of bank on which cheque/Banker’s cashier order is drawn (see “How to make your application” section) 兌現支 票╱銀行本票的銀行名稱(見「申請手續」一節)

HK$ 港元

Name in English 英文姓名╱名稱

Family name or company name 姓氏或公司名稱 Forename(s) 名字 Name in Chinese 中文姓名╱名稱中文姓名╱名稱╱名稱名稱 Family name or company name 姓氏或公司名稱 Forename(s) 名字 Occupation in English 職業(以英文填寫) Hong Kong Identity Card No./Passport No./Hong Kong Business Registration No. (Please delete as appropriate) 香港身份證號 碼╱護照號碼╱香港商業登記號碼(請刪除不適用者) Names of all other joint applicants in English (if any) Hong Kong Identity Card No./Passport No./Hong Kong Business 所有其他聯名申請人的英文姓名╱名稱(如有) Registration No. of all other joint applicants (Please delete as appropriate) 所有其他聯名申請人的香港身份證號碼╱護照 1) 號碼╱香港商業登記號碼(請刪除不適用者) 2) 1) 2) 3) 3) Hong Kong address in English and telephone no. (joint applicants should give the address and the telephone number of first-named applicant only) 香港地址(以英文填寫)及電話號碼(聯名申請人只須填寫排名首位申請人的地址及電話號碼)香港地址(以英文填寫)及電話號碼(聯名申請人只須填寫排名首位申請人的地址及電話號碼) Telephone No. 電話號碼 For Nominees: You will be treated as applying for your own benefit if you do not complete this section. Please provide an account number or identification code for each (joint) beneficial owner. 由代名人遞交:代名人若不填寫本節,是項申請將視作 為 閣下本身利益提出。請填寫每名(聯名)實益擁有人的賬 戶號碼或識別編碼。

Name in Chinese 中文姓名╱名稱中文姓名╱名稱╱名稱名稱

Hong Kong address in English and telephone no. (joint applicants should give the address and the telephone number of first-named applicant only) 香港地址(以英文填寫)及電話號碼(聯名申請人只須填寫排名首位申請人的地址及電話號碼)香港地址(以英文填寫)及電話號碼(聯名申請人只須填寫排名首位申請人的地址及電話號碼)

ADDRESS LABEL 地址標貼 ( Your name(s) and address in Hong Kong in BLOCK letters 請用 正楷 填寫 姓名╱名稱 及香 港 地址 )

For Internal use 此欄供內部使用

Please use this form if you want the Hong Kong Offer Shares to be issued in your name 如 閣下欲以本身名義登記將獲發行的香港發售股份,請使用本表格

  • *(1) An individual must provide his Hong Kong Identity Card number or, if he does not hold a Hong Kong Identity Card, his passport number. A body corporate must provide its Hong Kong Business Registration number. Each joint applicant must provide its or his relevant number. The Hong Kong Identity Card number(s)/passport number(s)/Hong Kong Business Registration number(s) will be transferred to a third party for checking the Application Form’s validity. 個別人士須填寫其香港身份證號碼或(如非香港身份證持有人)護照號碼。法 人團體須填寫其香港商業登記號碼。每名聯名申請人均須提供其相關號碼。該等香港身份證號碼╱護照 號碼╱香港商業登記號碼將轉交第三方以核實申請表格的有效性。

  • (2) Part of the Hong Kong Identity Card number/passport number of you or, for joint applicants, the first-named applicant may be printed on your refund cheque (if any). Your banker may require verification of your Hong Kong Identity Card number/passport number before you can cash your refund cheque. 退款支票(如有)上或會印 有 閣下或(如屬聯名申請人)排名首位申請人的香港身份證號碼╱護照號碼的一部分。銀行兌現退款支 票前或會要求查證 閣下的香港身份證號碼╱護照號碼。

  • If an application is made by an unlisted company and: • the principal business of that company is dealing in securities; and • you exercise statutory control over that company,

  • then the application will be treated as being made for your benefit. 倘若申請人是一家非上市公司,而: • 該公司主要從事證券買賣業務;及 • 閣下對該公司可行使法定控制權,

  • 則是項申請將視作為 閣下的利益提出。

  • (3) If an application is made by an unlisted company and:

This page is intentionally left blank 此乃白頁 特意留空

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

How to make your application

  1. Use the table below to calculate how much you must pay. Your application must be for a minimum of 500 Hong Kong Offer Shares and in one of the numbers set out in the table, or your application will be rejected.

CHUANGMEI PHARMACEUTICAL CO., LTD. (HK$8.60 per Hong Kong Offer Share) NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS

CHUANGMEI PHARMACEUTICAL CO., LTD.
(HK$8.60 per Hong Kong Offer Share)
NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
CHUANGMEI PHARMACEUTICAL CO., LTD.
(HK$8.60 per Hong Kong Offer Share)
NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
CHUANGMEI PHARMACEUTICAL CO., LTD.
(HK$8.60 per Hong Kong Offer Share)
NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
CHUANGMEI PHARMACEUTICAL CO., LTD.
(HK$8.60 per Hong Kong Offer Share)
NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
CHUANGMEI PHARMACEUTICAL CO., LTD.
(HK$8.60 per Hong Kong Offer Share)
NUMBER OF SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
Number of
Hong Kong Offer
Shares applied for
Amount payable
on application
HK$
Number of
Hong Kong Offer
Shares applied for
Amount payable
on application
HK$
Number of
Hong Kong Offer
Shares applied for
Amount payable
on application
HK$
500
4,343.34
1,000
8,686.66
1,500
13,030.00
2,000
17,373.32
2,500
21,716.66
3,000
26,059.99
3,500
30,403.32
4,000
34,746.65
4,500
39,089.98
5,000
43,433.31
6,000
52,119.97
7,000
60,806.64
8,000
69,493.30
9,000
78,179.96
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000
50,000
60,000
70,000
80,000
90,000
100,000
86,866.62
130,299.93
173,733.24
217,166.56
260,599.87
304,033.18
347,466.49
390,899.80
434,333.11
521,199.73
608,066.35
694,932.98
781,799.60
868,666.22
e
200,000
1,737,332.44
300,000
2,605,998.66
400,000
3,474,664.88
500,000
4,343,331.10
600,000
5,211,997.32
700,000
6,080,663.54
800,000
6,949,329.76
900,000
7,817,995.98
1,000,000
8,686,662.20
1,100,000
9,555,328.42
1,200,000
10,423,994.64
1,300,000
11,292,660.86
1,400,000(1)
12,161,327.08
(1)
Maximum number of Hong Kong Offer
Shares you may apply for.
2. Complete the form in English and sign it. Only written signatures will be accepted (and not by way of personal
chop).
3. Staple your cheque or banker’s cashier order to the form. Each application for the Hong Kong Offer Shares must
be accompanied by either one separate cheque or one separate banker’s cashier order. Your application will be
rejected if your cheque or banker’s cashier order does not meet all the following requirements:
Samp
The cheque must:
Banker’s cashier order must:

be in Hong Kong dollars;

not be post-dated;

be made payable to “ICBC (Asia) Nominee Limited – Chuangmei Pharmaceutical Public Offer”;

be crossed “Account Payee Only”;

be drawn on your Hong Kong dollar bank account
in Hong Kong; and

show your account name, which must either be pre-
printed on the cheque, or be endorsed on the back
by a person authorised by the bank. This account
name must correspond with your name. If it is a
joint application, the account name must be the
same as the first-named applicant’s name.

be issued by a licensed bank in Hong Kong, and
have your name certified on the back by a person
authorised by the bank. The name on the banker’s
cashier order must correspond with your name. If
it is a joint application, the name on the back of the
banker’s cashier order must be the same as the first-
named applicant’s name.
  1. Complete the form in English and sign it. Only written signatures will be accepted (and not by way of personal chop).

  2. Staple your cheque or banker’s cashier order to the form. Each application for the Hong Kong Offer Shares must be accompanied by either one separate cheque or one separate banker’s cashier order. Your application will be rejected if your cheque or banker’s cashier order does not meet all the following requirements:

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

  1. Tear off the Application Form, fold it once and lodge your completed Application Form (with cheque or banker’s cashier order attached) to one of the collection boxes at any of the following branches of Industrial and Commercial Bank of China (Asia) Limited:

District Branch name Branch address Hong Kong Island West Point Branch 242-244 Queen’s Road West, Sai Ying Pun Queen’s Road Central Branch 122-126 Queen’s Road Central, Central Causeway Bay Branch Shop A on G/F, 1/F, Hennessy Apartments, 488 & 490 Hennessy Road Kowloon Tsim Sha Tsui Branch Shop 1&2, G/F, No. 35-37 Hankow Road, Tsim Sha Tsui Mei Foo Branch Shop N95A, 1/F, Mount Sterling Mall, Mei Foo Sun Chuen Prince Edward Branch 777 Nathan Road, Mongkok Ngau Tau Kok Branch Shop Nos. G211-214, G/F, Phase II, Amoy Plaza, 77 Ngau Tau Kok Road New Territories Tsuen Wan Castle Peak Road Branch G/F, 423-427 Castle Peak Road, Tsuen Wan Kwai Fong Branch C63A-C66, 2/F, Kwai Chung Plaza, Kwai Fong Tuen Mun Branch 217 A-F Central Services Building, Nan Fung Industrial City, 18 Tin Hau Road, Tuen Mun Tai Po Branch Shop F, G/F, Mee Fat Building, No 34-38 Tai Wing Lane, Tai Po Shatin Branch Shop 22J, Level 3, Shatin Centre 5. Your Application Form can be lodged at these times: — Wednesday, 2 December 2015 9:00 a.m. to 5:00 p.m. — Thursday, 3 December 2015 9:00 a.m. to 5:00 p.m. — Friday, 4 December 2015 9:00 a.m. to 5:00 p.m. — Saturday, 5 December 2015 9:00 a.m. to 1:00 p.m. Monday, 7 December 2015 — 9:00 a.m. to 12:00 noon

  1. Your Application Form can be lodged at these times:

  2. The latest time for lodging your application is 12:00 noon on Monday, 7 December 2015. The application lists will be open between 11:45 a.m. and 12:00 noon on that day, subject only to the weather conditions, as described in “10. Effect of Bad Weather on the Opening of the Application Lists” in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus.

如 閣下欲以本身名義登記將獲發行的香港發售股份,請使用本表格

申請手續

  1. 使用下表計算 閣下應付的款項。 閣下申請認購的股數須至少為500股香港發售股份,並為下表所列的其 中一個數目,否則恕不受理。
創美藥業股份有限公司
(每股香港發售股份8.60港元)
可供申請認購股份數目及應繳款項
申請認購的
香港發售
股份數目
申請時
應繳股款
港元
申請認購的
香港發售
股份數目
申請時
應繳股款
港元
申請認購的
香港發售
股份數目
申請時
應繳股款
港元
500
4,343.34
1,000
8,686.66
1,500
13,030.00
2,000
17,373.32
2,500
21,716.66
3,000
26,059.99
3,500
30,403.32
4,000
34,746.65
4,500
39,089.98
5,000
43,433.31
6,000
52,119.97
7,000
60,806.64
8,000
69,493.30
9,000
78,179.96
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000
50,000
60,000
70,000
80,000
90,000
100,000
l
86,866.62
130,299.93
173,733.24
217,166.56
260,599.87
304,033.18
347,466.49
390,899.80
434,333.11
521,199.73
608,066.35
694,932.98
781,799.60
868,666.22
e
200,000
1,737,332.44
300,000
2,605,998.66
400,000
3,474,664.88
500,000
4,343,331.10
600,000
5,211,997.32
700,000
6,080,663.54
800,000
6,949,329.76
900,000
7,817,995.98
1,000,000
8,686,662.20
1,100,000
9,555,328.42
1,200,000
10,423,994.64
1,300,000
11,292,660.86
1,400,000(1)
12,161,327.08
(1)
閣下可申請認購的香港發售股份最高數
目。
2.以英文填妥及簽署申請表格。只接納親筆簽名(不得以個人印章代替)。
3.閣下須將支票或銀行本票釘於表格上。每份香港發售股份申請須附一張獨立開出支票或一張獨立開出銀行
本票。支票或銀行本票必須符合以下所有規定,否則有關的認購申請不獲接納:
Sam
支票必須:
銀行本票必須:

為港元;

不得為期票;

註明抬頭人為「工銀亞洲代理人有限公司-創美藥業公開發售」;

劃線註明「只准入抬頭人賬戶」;

從 閣下在香港的港元銀行賬戶中開出;及

顯示 閣下的賬戶名稱,而該賬戶名稱必須已
預印在支票上,或由有關銀行授權的人士在支
票背書。賬戶名稱必須與 閣下姓名╱名稱相
同。如屬聯名申請,賬戶名稱必須與排名首位
申請人的姓名╱名稱相同。

須由香港持牌銀行開出,並由有關銀行授權的
人士在銀行本票背面簽署核證 閣下姓名╱名
稱。銀行本票所示姓名╱名稱必須與 閣下姓
名╱名稱相同。如屬聯名申請,銀行本票背面
所示姓名╱名稱必須與排名首位申請人的姓
名╱名稱相同。

如 閣下欲以本身名義登記將獲發行的香港發售股份,請使用本表格

  1. 請撕下申請表格,對摺一次,然後將填妥的申請表格(連同支票或銀行本票)投入中國工商銀行(亞州)有限 公司下列任何一家分行特設的收集箱:

地區 分行名稱 分行地址 香港島 西環分行 西營盤皇后大道西242-244號 皇后大道中分行 中環皇后大道中122-126號 銅鑼灣分行 銅鑼灣軒尼詩道488-490號軒尼詩大廈地下A舖至1樓 九龍 尖沙咀分行 尖沙咀漢口道35至37號地下1-2號舖 美孚分行 美孚新村萬事達廣場一樓N95A舖 太子分行 旺角彌敦道777號 牛頭角分行 牛頭角道77號淘大商場第二期地下211-214號舖 新界 荃灣青山公路分行 青山公路荃灣段423-427號地下 葵芳分行 葵芳葵涌廣場二字樓C63A-C66號舖 屯門分行 屯門天后路18號南豐工業城中央服務大樓217號A-F 大埔分行 大埔大榮里34至38號美發大廈地下F舖 沙田分行 沙田中心3樓22J號舖 5. 閣下可於下列時間遞交申請表格: 2015年12月2日(星期三)[—] 上午9時正至下午5時正 2015年12月3日(星期四)[—] 上午9時正至下午5時正 2015年12月4日(星期五)[—] 上午9時正至下午5時正 2015年12月5日(星期六)[—] 上午9時正至下午1時正 2015年12月7日(星期一)[—] 上午9時正至中午12時正 6. 截止遞交申請的時間為2015年12月7日(星期一)中午12時正。本公司將於當日上午11時45分至中午12時正 期間登記認購申請,唯一會影響此時間變化的因素為當日的天氣情況(詳見招股說明書「如何申請香港發售 股份」一節「10. 惡劣天氣對開始辦理申請登記的影響」)。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

==> picture [79 x 66] intentionally omitted <==

CHUANGMEI PHARMACEUTICAL CO., LTD.[*] 創美藥業股份有限公司

(a joint stock limited liability company established in the People’s Republic of China)

GLOBAL OFFERING

Conditions of your application

  • confirm that you have read the terms and conditions and application procedures set out in the Prospectus and in this Application Form and agree to be bound by them;

  • A. Who can apply

  • You and any person(s) for whose benefit you are applying must be 18 years of age or older and must have a Hong Kong address.

  • confirm that you have received and read the Prospectus and have only relied on the information and representations contained in the Prospectus in making your application and will not rely on any other information or representations except those in any supplement to the Prospectus;

  • If you are a firm, the application must be in the individual members’ names.

  • The number of joint applicants may not exceed 4. supplement to the Prospectus;

  • If you are a body corporate, the application must be signed by • a duly authorised officer, who must state his representative Offering in the Prospectus;

capacity, and stamped with your corporation’s chop. •

  1. You must be outside the United States, not be a United States Person (as defined in Regulation S under the U.S. Securities Act) and not be a legal or natural person of the PRC (unless permitted by the relevant rules and regulations).

  2. Unless permitted by the Listing Rules, you cannot apply for any supplement to it);

Hong Kong Offer Shares if you are: • • an existing beneficial owner of shares in the Company and/ or any of its subsidiaries;

• a director or chief executive officer of the Company and/or any of its subsidiaries;

• a connected person (as defined in the Listing Rules) of • the Company or will become a connected person of the Company immediately upon completion of the Global Offering;

• an associate (as defined in the Listing Rules) of any of the above; or •

• have been allocated or have applied for or indicated an interest in any Offer Shares under the International Offering.

B. If you are a nominee You, as a nominee, may make more than one application for the Hong Kong Offer Shares by: (i) giving electronic application instructions to HKSCC via Central Clearing and Settlement System (“ CCASS ”) (if you are a CCASS Participant); or (ii) using a WHITE or YELLOW Application Form;

Application Form, and lodge more than one application in your own name on behalf of different beneficial owners. •

  • confirm that you are aware of the restrictions on the Global Offering in the Prospectus;

• agree that none of the Company, the Sole Sponsor, the Sole Global Coordinator, the Underwriters, their respective directors, officers, employees, partners, agents, advisers and any other parties involved in the Global Offering is or will be liable for any information and representations not in the Prospectus (and any supplement to it); • undertake and confirm that you or the person(s) for whose benefit you have made the application have not applied for or taken up, or indicated an interest for, and will not apply for or take up, or indicate an interest for, any Offer Shares under the International Offering nor participated in the International Offering;

agree to disclose to the Company, the H Share Registrar, the receiving bank, the Sole Sponsor, the Sole Global Coordinator, the Underwriters and/or their respective advisers and agents any personal data which they may require about you and the person(s) for whose benefit you have made the application;

  • if the laws of any place outside Hong Kong apply to your application, agree and warrant that you have complied with all such laws and none of the Company, the Sole Sponsor, the Sole Global Coordinator, and the Underwriters nor any of their respective officers or advisers will breach any law outside Hong Kong as a result of the acceptance of your offer to purchase, or any action arising from your rights and obligations under the terms and conditions contained in the Prospectus and this Application Form;

  • agree that once your application has been accepted, you may not rescind it because of an innocent misrepresentation;

C. Effect of completing and submitting this Application Form

  • agree that your application will be governed by the laws of Hong Kong;

By completing and submitting this Application Form, you (and if you are joint applicants, each of you jointly and severally) for yourself or as an agent or a nominee on behalf of each person for whom you act:

  • represent, warrant and undertake that (i) you understand that the Hong Kong Offer Shares have not been and will not be registered under the U.S. Securities Act; and (ii) you and any person for whose benefit you are applying for the Hong Kong Offer Shares are outside the United States (as defined in Regulation S) or are a person described in paragraph (h)(3) of Rule 902 of Regulation S;

  • undertake to execute all relevant documents and instruct and authorise the Company and/or the Sole Global Coordinator (or their agents or nominees), as agents of the Company, to execute any documents for you and to do on your behalf all things necessary to register any Hong Kong Offer Shares allocated to you in your name as required by the Articles of Association;

  • warrant that the information you have provided is true and accurate;

  • agree to comply with the Companies Ordinance, the Companies (Winding Up and Miscellaneous Provisions) Ordinance, the PRC Company Law, the Special Regulations and the Articles of Association;

  • agree to accept the Hong Kong Offer Shares applied for, or any lesser number allocated to you under the application;

  • authorise the Company to place your name(s) on the Company’s register of members as the holder(s) of any Hong Kong Offer

  • For identification purpose only

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

  • Shares allocated to you, and the Company and/or its agents to send any H Share certificate(s) and/or any refund cheque(s) to you or the first-named applicant for joint application by ordinary post at your own risk to the address stated on the application, unless you are eligible to collect the H Share certificate(s) and/or any refund cheque(s) in person;

may collect your refund cheque(s) and/or H Share certificate(s) in person from: Computershare Hong Kong Investor Services Limited at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong, from 9:00 a.m. to 1:00 p.m. on Friday, 11 December 2015 or such other date as notified by us in the newspapers.

If you are an individual who is eligible for personal collection, you must not authorise any other person to collect for you. If you are a corporate applicant which is eligible for personal collection, your authorised representative must bear a letter of authorisation from your corporation stamped with your corporation’s chop. Both individuals and authorised representatives must produce, at the time of collection, evidence of identity acceptable to Computershare Hong Kong Investor Services Limited.

  • declare and represent that this is the only application made and the only application intended by you to be made to benefit you or the person for whose benefit you are applying;

  • understand that the Company, the Sole Sponsor and the Sole Global Coordinator, will rely on your declarations and representations in deciding whether or not to make any allotment of any of the Hong Kong Offer Shares to you and that you may be prosecuted for making a false declaration;

  • (if the application is made for your own benefit) warrant that no other application has been or will be made for your benefit on a WHITE or YELLOW Application Form or by giving electronic application instructions to HKSCC or through the White Form eIPO Service by you or by any one as your agent or by any other person; and

If you do not collect your refund cheque(s) and/or H Share certificate(s) personally within the time period specified for collection, they will be dispatched promptly to the address as specified on this Application Form by ordinary post at your own risk.

If you apply for less than 1,000,000 Hong Kong Offer Shares, your refund cheque(s) and/or share certificate(s) will be sent to the address on the relevant Application Form on or before Friday, 11 December 2015, by ordinary post and at your own risk.

refund cheque(s) and/or share certificate(s) will be sent to the address on the relevant Application Form on or before Friday, 11 December 2015, by ordinary post and at your own risk. Refund of your money Application Form or by giving electronic If you do not receive any Hong Kong Offer Shares or if your application is accepted only in part, the Company will refund to you your application monies (including the related 1% brokerage, 0.0027% SFC transaction levy and 0.005% Hong Kong Stock Exchange trading fee) without interest. If the offer price is less than the maximum Offer Price, the Company will refund to you the surplus application monies (including the related 1% brokerage, 0.0027% SFC transaction levy and 0.005% Hong Kong Stock Exchange trading fee) without interest. The refund procedures are stated in the “14. Despatch/Collection of H Share Certificates and Refund Monies” in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus. Application by HKSCC Nominees Limited (“HKSCC Nominees”) Where this Application Form is signed by HKSCC Nominees on behalf of persons who have given electronic application instructions to apply for the Hong Kong Offer Shares, the provisions of this Application Form which are inconsistent with those set out in the Prospectus shall not apply and provisions in the Prospectus shall prevail. Without limiting the generality of this paragraph, the following sections of this Application Form are inapplicable where this form is signed by HKSCC Nominees:

  • (if you are making the application as an agent for the benefit of another person) warrant that (i) no other application has been or will be made by you as agent for or for the benefit of that person or by that person or by any other person as agent for that person on a WHITE or YELLOW Application Form or by giving electronic application instructions to HKSCC and (ii) you have due authority to sign the Application Form or give electronic application instructions on behalf of that other person as their agent.

a or Application Form or by giving electronic If you do not receive any Hong Kong Offer Shares or if your application instructions to HKSCC and (ii) you have due authority application is accepted only in part, the Company will refund to you to sign the Application Form or give electronic application your application monies (including the related 1% brokerage, 0.0027% instructions on behalf of that other person as their agent. SFC transaction levy and 0.005% Hong Kong Stock Exchange trading fee) without interest. If the offer price is less than the maximum Offer D. Power of attorney Price, the Company will refund to you the surplus application monies If your application is made through an authorised attorney, the (including the related 1% brokerage, 0.0027% SFC transaction levy Company and the Sole Global Coordinator may accept or reject your and 0.005% Hong Kong Stock Exchange trading fee) without interest. application at their discretion, and on any conditions they think fit,

including evidence of the attorney’s authority.

The refund procedures are stated in the “14. Despatch/Collection of H Share Certificates and Refund Monies” in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus.

Determination of Offer Price and Allocation of Hong Kong Offer Shares The Offer Price is expected to be fixed on or around Monday, 7 December 2015 but in any event, not later than Thursday, 10 December 2015. Applicants are required to pay the maximum Offer Price of HK$8.60 for each Hong Kong Offer Share together with 1% brokerage, 0.0027% SFC transaction levy and 0.005% Stock Exchange trading fee. If the Offer Price is not agreed between the Company and the Sole Global Coordinator (on behalf of the underwriters) on or before Thursday, 10 December 2015, the Global Offering will not proceed.

Applications for Hong Kong Offer Shares will not be processed and no allotment of any Hong Kong Offer Shares will be made until the application lists close.

  • “Applicants’ declaration” on the first page;

  • “Warning” on the first page;

  • “If you are a nominee”;

  • All representations and warranties under the “Effect of completing and submitting this Application Form” section, except the first one regarding registration of Hong Kong Offer Shares in the applicant’s name and the signing of documents to enable the applicant to be registered as the holder of the Hong Kong Offer Shares;

The Company expects to announce the fixed offer price, the indication of the level of interest in the International Offering, the level of applications under the Hong Kong Public Offering and the basis of allocation of the Hong Kong Public Offering on Friday, 11 December 2015 in the South China Morning Post (in English), the Hong Kong Economic Times (in Chinese), on the website of the Hong Kong Stock Exchange at www.hkexnews.hk and the Company’s website at www.chmyy.com. Results of allocations in Hong Kong Public Offering, and the Hong Kong Identity Card/passport/Hong Kong business registration numbers of successful applicants (where applicable) will be available on the above websites.

  • “If your application for Hong Kong Offer Shares is successful (in whole or in part)”; and

  • “Refund of your money”.

The following sections in the “How to Apply for Hong Kong Offer Shares” section of the Prospectus are inapplicable where this form is signed by HKSCC Nominees:

If your application for Hong Kong Offer Shares is successful (in whole or in part)

  • “8. How many applications may you make”; and

  • “12. Circumstances in which you will not be allotted Hong Kong Offer Shares”.

If you apply for 1,000,000 or more Hong Kong Offer Shares, you

如 閣下欲以本身名義登記將獲發行的香港發售股份,請使用本表格

==> picture [79 x 66] intentionally omitted <==

CHUANGMEI PHARMACEUTICAL CO., LTD.[*] 創美藥業股份有限公司

(於中華人民共和國註冊成立的股份有限公司)

全球發售

  • ‧ 確認 閣下已細閱招股說明書及本申請表格所載 的條款及條件以及申請程序,並同意受其約束;

申請條件

甲、可提出申請的人士 確認 閣下已接獲及細閱招股說明書,提出申請 1. 閣下及 閣下為其利益提出申請的人士必須年滿 時也僅依據招股說明書載列的資料及陳述,而除 18歲並有香港地址。 招股說明書任何補充文件外,不會依賴任何其他 2. 如 閣下為商號,申請須以個別成員名義提出。 資料或陳述; 3. 聯名申請人不得超過四名。 ‧ 確認 閣下知悉招股說明書內有關全球發售的限 4. 如 閣下為法人團體,申請須經獲正式授權人員 制; ‧ 簽署,並註明其所屬代表身份及蓋上公司印鑑。 同意本公司、獨家保薦人、獨家全球協調人、包 5. 閣下必須身處美國境外,並非美籍人士(定義見美 銷商、彼等各自的董事、高級職員、僱員、合夥 國證券法S規例),亦非中國法人或自然人(除非獲 人、代理、顧問及參與全球發售的任何其他人士 有關規則及法規批准)。 現時及日後均毋須對並非載於招股說明書(及其任 6. 除上市規則批准外,下列人士概不得申請認購任 何補充文件)的任何資料及陳述負責; ‧ 何香港發售股份: 承諾及確認 閣下或 閣下為其利益提出申請的 ‧ 本公司及╱或其任何附屬公司股份的現有實 人士並無申請或接納或表示有意認購(亦不會申請 益擁有人; 或接納或表示有意認購)國際發售的任何發售股 ‧ 本公司及╱或其任何附屬公司的董事或首席 份,也沒有參與國際發售; 執行官; ‧ 同意在本公司、H股證券登記處、收款銀行、獨 ‧ 本公司關連人士(定義見上市規則)或緊隨全 家保薦人、獨家全球協調人、包銷商及╱或彼等 球發售完成後成為本公司關連人士的人士; 各自的顧問及代理提出要求時,向彼等披露其所 ‧ 上述任何人士的聯繫人(定義見上市規則); 要求提供有關 閣下及 閣下為其利益提出申請 或 的人士的個人資料; ‧ ‧ 已獲分配或已申請或表示有意申請國際發售 若香港境外任何地方的法例適用於 閣下的申 的任何發售股份的人士。 請,則同意及保證 閣下已遵守所有有關法例, 且本公司、獨家保薦人、獨家全球協調人及包 乙、如 閣下為代名人 銷商和彼等各自的高級職員或顧問概不會因接 閣下作為代名人可提交超過一份香港發售股份申請, 納 閣下的購買要約,或 閣下在招股說明書及 方法是:(i)透過中央結算及交收系統(「 中央結算系 本申請表格所載的條款及條件下的權利及責任所 」)向香港結算發出電子認購指示(如 閣下為中央 引致的任何行動,而違反香港境外的任何法例; ‧ 結算系統參與者);或(ii)使用 白色黃色 申請表格, 同意 閣下的申請一經接納,即不得因無意的失 以自身名義代表不同的實益擁有人提交超過一份申 實陳述而撤銷; ‧ 請。 同意 閣下的申請受香港法例規管;

  • ‧ 同意 閣下的申請受香港法例規管;

  • ‧ 聲明、保證及承諾:(i) 閣下明白香港發售股份 不曾亦不會根據美國證券法登記;及(ii) 閣下 及 閣下為其利益申請香港發售股份的人士均身 處美國境外(定義見S規例)或屬S規例第902條第 (h)(3)段所述的人士;

丙、填寫及遞交本申請表格的效用

閣下填妥並遞交本申請表格,即表示 閣下(如屬聯 名申請人,即各人共同及個別)代表 閣下本身,或 作為 閣下代其行事的每位人士的代理或代名人:

  • ‧ 保證 閣下提供的資料真實及準確;

  • ‧ 承諾簽立所有相關文件,並指示及授權本公司 及╱或作為本公司代理的獨家全球協調人(或彼等 的代理或代名人),代表 閣下簽立任何文件,並 按照公司章程的規定將 閣下獲分配的任何香港 發售股份以 閣下名義登記;

  • ‧ 同意接納所申請數目或根據申請分配予 閣下但 數目較少的香港發售股份;

  • ‧ 授權本公司將 閣下的姓名╱名稱列入本公司股 東名冊,作為 閣下獲分配的任何香港發售股份 的持有人,並授權本公司及╱或其代理以普通郵 遞方式按申請所示地址向 閣下或聯名申請的首

  • ‧ 同意遵守公司條例、公司(清盤及雜項條文)條 例、中國公司法、特別規定及公司章程;

  • 僅供識別

如 閣下欲以本身名義登記將獲發行的香港發售股份,請使用本表格

  • 名申請人發送任何H股股票及╱或退款支票,郵 誤風險由 閣下承擔,除非 閣下合資格親身領 取H股股票及╱或任何退款支票;

后大道東183號合和中心17樓1712-1716室)領取退款支 票及╱或H股股票。

如 閣下為個人申請人並合資格親身領取, 閣下不 得授權任何其他人士代領。如 閣下為公司申請人並 合資格派人領取, 閣下的授權代表須攜同蓋上公司 印鑑的授權書領取。個人申請人及授權代表領取時均 須出示香港中央證券登記有限公司接納的身份證明文 件。

  • ‧ 聲明及表示此乃 閣下為本身或 閣下為其利益 提出申請的人士提出及擬提出的唯一申請;

  • ‧ 明白本公司、獨家保薦人及獨家全球協調人將依 據 閣下的聲明及陳述而決定是否向 閣下分配 任何香港發售股份, 閣下如作出虛假聲明,可能 會被檢控;

  • ‧ (如本申請為 閣下本身的利益提出)保證 閣下 或作為 閣下代理的任何人士或任何其他人士不 曾亦不會為 閣下的利益以 白色黃色 申請表格 或向香港結算或透過 白表eIPO 服務發出電子認購 指示而提出其他申請;及

如 閣下並無在指定領取時間內親身領取退款支票 及╱或H股股票,有關退款支票及╱或H股股票將會 立刻以普通郵遞方式寄往本申請表格所示地址,郵誤 風險由 閣下承擔。

‧ (如 閣下作為代理為另一人士的利益提出申請) 如 閣下申請認購 1,000,000 股以下香港發售股 股以下香港發售股 保證(i) 閣下(作為代理或為該人士利益)或該人 份, 閣下的退款支票及╱或股票將於2015年12月112015年12月11年12月1112月11月1111 士或任何其他作為該人士代理的人士不曾亦不會 日(星期五)或之前以普通郵遞方式寄往相關申請表格 以 白色黃色 申請表格或向香港結算發出電子認 所示地址,郵誤風險由 閣下承擔。 購指示而提出其他申請及(ii) 閣下獲正式授權作 退回股款 為該人士的代理代為簽署本申請表格或發出電子 若 閣下未獲分配任何香港發售股份或申請僅部分 認購指示。 獲接納,本公司將不計利息退回 閣下的申請股款 (包括相關1%經紀佣金、0.0027%證監會交易徵費及 丁、授權書 0.005%香港聯交所交易費)。如最終釐定的發售價低 如 閣下透過授權人士提出申請,本公司及獨家全球 於最高發售價,本公司將不計利息退回多收申請股款 協調人可按其認為合適的條件(包括出示獲授權證明) (包括相關的1%經紀佣金、0.0027%證監會交易徵費 酌情接納或拒絕 閣下的申請。 及0.005%香港聯交所交易費)。 釐定發售價及香港發售股份的分配 有關退款程序載於招股說明書「如何申請香港發售股 預期發售價於2015年12月7日(星期一)或前後釐定,2015年12月7日(星期一)或前後釐定,年12月7日(星期一)或前後釐定,12月7日(星期一)或前後釐定,月7日(星期一)或前後釐定,7日(星期一)或前後釐定,日(星期一)或前後釐定, 份」一節「14. 發送╱領取H股股票及退回股款」。14. 發送╱領取H股股票及退回股款」。發送╱領取H股股票及退回股款」。H股股票及退回股款」。股股票及退回股款」。 惟於任何情況下均不會遲於2015年12月10日(星期2015年12月10日(星期年12月10日(星期12月10日(星期月10日(星期10日(星期日(星期 四)。申請人須繳付每股香港發售股份8.60港元的最高8.60港元的最高港元的最高 香港中央結算(代理人)有限公司(「香港結算代理人」) 發售價,另加1%經紀佣金、0.0027%證監會交易徵費1%經紀佣金、0.0027%證監會交易徵費經紀佣金、0.0027%證監會交易徵費0.0027%證監會交易徵費證監會交易徵費 提出的申請 如本申請表格由香港結算代理人代表發出電子認購指 及0.005%聯交所交易費。倘若本公司與獨家全球協調0.005%聯交所交易費。倘若本公司與獨家全球協調聯交所交易費。倘若本公司與獨家全球協調 示申請香港發售股份的人士簽署,本申請表格與招股 人(代表包銷商)並無於2015年12月10日(星期四)或之2015年12月10日(星期四)或之年12月10日(星期四)或之12月10日(星期四)或之月10日(星期四)或之10日(星期四)或之日(星期四)或之 說明書不符的條文將不適用,且以招股說明書所述者 前協定發售價,全球發售將不會進行。 為準。 截止登記認購申請前,概不處理香港發售股份的申請 在不限制此段一般應用的前提下,本申請表格的以下 或配發任何香港發售股份。 部分在香港結算代理人作簽署人的情況下並不適用:

如 閣下申請認購 1,000,000 股以下香港發售股 股以下香港發售股 份, 閣下的退款支票及╱或股票將於2015年12月112015年12月11年12月1112月11月1111 日(星期五)或之前以普通郵遞方式寄往相關申請表格 所示地址,郵誤風險由 閣下承擔。

釐定發售價及香港發售股份的分配 有關退款程序載於招股說明書「如何申請香港發售股 預期發售價於2015年12月7日(星期一)或前後釐定,2015年12月7日(星期一)或前後釐定,年12月7日(星期一)或前後釐定,12月7日(星期一)或前後釐定,月7日(星期一)或前後釐定,7日(星期一)或前後釐定,日(星期一)或前後釐定, 份」一節「14. 發送╱領取H股股票及退回股款」。14. 發送╱領取H股股票及退回股款」。發送╱領取H股股票及退回股款」。H股股票及退回股款」。股股票及退回股款」。 惟於任何情況下均不會遲於2015年12月10日(星期2015年12月10日(星期年12月10日(星期12月10日(星期月10日(星期10日(星期日(星期 四)。申請人須繳付每股香港發售股份8.60港元的最高8.60港元的最高港元的最高 香港中央結算(代理人)有限公司(「香港結算代理人」) 發售價,另加1%經紀佣金、0.0027%證監會交易徵費1%經紀佣金、0.0027%證監會交易徵費經紀佣金、0.0027%證監會交易徵費0.0027%證監會交易徵費證監會交易徵費 提出的申請 如本申請表格由香港結算代理人代表發出電子認購指 及0.005%聯交所交易費。倘若本公司與獨家全球協調0.005%聯交所交易費。倘若本公司與獨家全球協調聯交所交易費。倘若本公司與獨家全球協調 示申請香港發售股份的人士簽署,本申請表格與招股 人(代表包銷商)並無於2015年12月10日(星期四)或之2015年12月10日(星期四)或之年12月10日(星期四)或之12月10日(星期四)或之月10日(星期四)或之10日(星期四)或之日(星期四)或之 說明書不符的條文將不適用,且以招股說明書所述者 前協定發售價,全球發售將不會進行。

  • ‧ 第一頁的「申請人聲明」;

本公司預期於2015年12月11日(星期五)在南華早報 (英文)、香港經濟日報(中文)、香港聯交所網站 www.hkexnews.hk及本公司網站www.chmyy.com公佈 協定發售價、國際發售的認購踴躍程度、香港公開發 售申請水平及香港公開發售分配基準。香港公開發售 的分配結果及成功申請人的香港身份證╱護照╱香港 商業登記號碼(如適用)亦同於上述網站公佈。

  • ‧ 第一頁的「警告」;

  • ‧ 「如 閣下為代名人」;

  • ‧ 「填寫及遞交本申請表格的效用」一節項下的所有 陳述及保證,惟首項有關以申請人名義登記香港 發售股份及簽署使申請人登記成為香港發售股份 持有人的文件除外;

  • ‧ 「如 閣下成功申請認購香港發售股份(全部或部 分)」;及

  • ‧ 「退回股款」。

如 閣下成功申請認購香港發售股份(全部或部分)

如 閣下申請認購 1,000,000 股或以上香港發售股 份, 閣下可於2015年12月11日(星期五)或本公司在 報章上公佈的其他日期上午9時正至下午1時正,親身 前往香港中央證券登記有限公司(地址為香港灣仔皇

招股說明書「如何申請香港發售股份」一節的以下部分 在香港結算代理人作簽署人的情況下並不適用: ‧ 「8. 閣下可提交的申請數目」;及

  • ‧ 「12. 閣下不獲配發香港發售股份的情況」。

Please use this form if you want the Hong Kong Offer Shares to be issued in your name

Personal Data

H Share Registrar to discharge their obligations to securities holders and/or regulators and/or any other purposes to which the securities holders may from time to time agree.

Personal Information Collection Statement

This Personal Information Collection Statement informs the applicant for, and holder of, Hong Kong Offer Shares, of the policies and practices of the Company and its H Share Registrar in relation to personal data and the Personal Data (Privacy) Ordinance (Chapter 486 of the Laws of Hong Kong) (the “Ordinance”).

3. Transfer of personal data

Personal data held by the Company and its H Share Registrar relating to the securities holders will be kept confidential but the Company and its H Share Registrar may, to the extent necessary for achieving any of the above purposes, disclose, obtain or transfer (whether within or outside Hong Kong) the personal data to, from or with any of the following:

1. Reasons for the collection of your personal data

It is necessary for applicants and registered holders of securities to supply correct personal data to the Company or its agents and the H Share Registrar when applying for securities or transferring securities into or out of their names or in procuring the services of the H Share Registrar.

  • the Company’s appointed agents such as financial advisers, receiving bankers and overseas principal share registrar;

• where applicants for securities request a deposit into CCASS, HKSCC or HKSCC Nominees, who will use the personal data for the purposes of operating CCASS;

Failure to supply the requested data may result in your use the personal data for the purposes of operating application for securities being rejected, or in delay or CCASS; the inability of the Company or its H Share Registrar • any agents, contractors or third-party service providers to effect transfers or otherwise render their services. It who offer administrative, telecommunications, may also prevent or delay registration or transfers of the computer, payment or other services to the Hong Kong Offer Shares which you have successfully Company or the H Share Registrar in connection applied for and/or the dispatch of H Share certificate(s) with their respective business operation; and/or refund cheque(s) to which you are entitled. • the Hong Kong Stock Exchange, the SFC and any other statutory regulatory or governmental bodies or It is important that securities holders inform the otherwise as required by laws, rules or regulations; Company and the H Share Registrar immediately of any and inaccuracies in the personal data supplied. • any persons or institutions with which the securities holders have or propose to have dealings, such as 2. Purposes their bankers, solicitors, accountants or stockbrokers The personal data of the securities holders may be used, etc. held, processed, and/or stored (by whatever means) for the following purposes: 4. Retention of personal data • processing your application and refund cheque, The Company and its H Share Registrar will keep the where applicable, verification of compliance with personal data of the applicants and holders of securities the terms and application procedures set out in for as long as necessary to fulfill the purposes for which this Application Form and the Prospectus and the personal data were collected. Personal data which announcing results of allocation of the Hong Kong is no longer required will be destroyed or dealt with in Offer Shares; accordance with the Ordinance. • compliance with applicable laws and regulations in Hong Kong and elsewhere; 5. Access to and correction of personal data

the inability of the Company or its H Share Registrar • any agents, contractors or third-party service providers to effect transfers or otherwise render their services. It who offer administrative, telecommunications, may also prevent or delay registration or transfers of the computer, payment or other services to the Hong Kong Offer Shares which you have successfully Company or the H Share Registrar in connection applied for and/or the dispatch of H Share certificate(s) with their respective business operation; and/or refund cheque(s) to which you are entitled. • the Hong Kong Stock Exchange, the SFC and any other statutory regulatory or governmental bodies or It is important that securities holders inform the otherwise as required by laws, rules or regulations; Company and the H Share Registrar immediately of any and

Securities holders have the right to ascertain whether the Company or the H Share Registrar hold their personal data, to obtain a copy of that data, and to correct any data that is inaccurate. The Company and the H Share Registrar have the right to charge a reasonable fee for the processing of such requests.

  • registering new issues or transfers into or out of the names of securities holders including, where applicable, HKSCC Nominees;

  • maintaining or updating the register of securities holders of the Company;

  • verifying securities holders’ identities;

  • establishing benefit entitlements of securities holders of the Company, such as dividends, rights issues, bonus issues, etc.;

All requests for access to data or correction of data should be addressed to us, at our registered address disclosed in the “Corporate Information” section of the Prospectus or as notified from time to time, for the attention of the company secretary, or our H Share Registrar for the attention of the privacy compliance officer.

  • distributing communications from the Company and its subsidiaries;

  • compiling statistical information and securities holder profiles;

  • disclosing relevant information to facilitate claims on entitlements; and

By signing an Application Form or by giving electronic application instructions to HKSCC, you agree to all of the above.

  • any other incidental or associated purposes relating to the above and/or to enable the Company and the

如 閣下欲以本身名義登記將獲發行的香港發售股份,請使用本表格

個人資料

及╱或監管機構承擔的責任及╱或證券持有人 不時同意的任何其他目的。

個人資料收集聲明

3. 轉交個人資料

此項個人資料收集聲明是向香港發售股份的申請人 及持有人說明有關本公司及其H股證券登記處有關 個人資料及香港法例第486章個人資料(私隱)條例 (「條例」)方面的政策及慣例。

本公司及其H股證券登記處所持有關證券持有人的 個人資料將會保密,但本公司及其H股證券登記處 可以在為達到上述任何目的之必要情況下,向下列 任何人士披露、獲取或轉交(無論在香港境內或境 外)有關個人資料:

1. 收集 閣下個人資料的原因

  • ‧ 本公司委任的代理人,例如財務顧問、收款銀 行和主要海外股份過戶登記處;

證券申請人及登記持有人以本身名義申請證券或轉 讓或受讓證券時或尋求H股證券登記處的服務時, 必須向本公司或其代理人及H股證券登記處提供準H股證券登記處提供準股證券登記處提供準 確個人資料。

‧ (如證券申請人要求將證券存於中央結算系統) 必須向本公司或其代理人及H股證券登記處提供準H股證券登記處提供準股證券登記處提供準 香港結算或香港結算代理人;彼等將會就中央 確個人資料。 結算系統的運作使用有關個人資料; ‧ 向本公司或H股證券登記處提供與其各自業務營 未能提供所要求的資料可能導致 閣下的證券申請 運有關的行政、電訊、電腦、付款或其他服務 被拒或延遲,或本公司或其H股證券登記處無法落 的任何代理人、承包商或第三方服務供應商; 實轉讓或提供服務。此舉也可能妨礙或延遲登記 ‧ 香港聯交所、證監會及任何其他法定監管機關 或轉讓 閣下成功申請的香港發售股份及╱或寄 或政府部門或遵照法例、規則或法規的規定; 發 閣下應得的H股股票及╱或退款支票。 及 ‧ 證券持有人與其進行或擬進行交易的任何人士 證券持有人所提供的個人資料如有任何錯誤,須立 或機構,例如彼等的銀行、律師、會計師或股 即通知本公司及H股證券登記處。 票經紀等。 2. 目的 4. 個人資料的保留 證券持有人的個人資料可被採用及以任何方式持 本公司及其H股證券登記處將按收集個人資料所需 有、處理及╱或保存,以作下列用途: 的用途保留證券申請人及持有人的個人資料。無需 ‧ 處理 閣下的申請及退款支票(如適用)、核實 保留的個人資料將會根據條例銷毀或處理。 是否符合本申請表格及招股說明書載列的條款 和申請程序以及公佈香港發售股份的分配結果;

5. 查閱及更正個人資料

  • ‧ 遵守香港及其他地區的適用法律及法規;

證券持有人有權確定本公司或H股證券登記處是否 持有其個人資料,並有權索取有關資料的副本並更 正任何不準確資料。本公司及H股證券登記處有權 就處理任何查閱資料的要求收取合理費用。

  • ‧ 以證券持有人(包括香港結算代理人(如適用)) 的名義登記新發行證券或轉讓或受讓證券;

  • ‧ 存置或更新本公司證券持有人的名冊;

  • ‧ 核實證券持有人的身份;

  • ‧ 確定本公司證券持有人的受益權利,例如股 息、供股、紅股等;

  • ‧ 分發本公司及其附屬公司的通訊;

  • ‧ 編製統計數據和證券持有人資料;

所有查閱資料或更正資料的要求應按招股說明書「公 司資料」一節所披露或不時通知的本公司註冊地址送 交公司秘書,或向本公司的H股證券登記處的個人 資料私隱事務主任提出。

  • ‧ 披露有關資料以便就權益索償;及

  • ‧ 與上述有關的任何其他附帶或相關目的及╱或 使本公司及H股證券登記處能履行對證券持有人

閣下簽署申請表格或向香港結算發出電子認購指 示,即表示同意上述各項。

This page is intentionally left blank 此乃白頁 特意留空

This page is intentionally left blank 此乃白頁 特意留空